Cycle Network Model of Prostaglandin H Synthase-1

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Prostaglandin H Synthase-1 (PGHS-1) is crucial for prostaglandin synthesis.
• Understanding its complex kinetics is vital for drug development.
• Non-steroidal anti-inflammatory drugs (NSAIDs) target PGHS-1, but their efficacy varies.

Purpose of the Study:

• To develop a detailed kinetic model of PGHS-1.
• To investigate the complex network dynamics and catalytic mechanism of PGHS-1.
• To assess the efficacy of NSAIDs in various conditions.

Main Methods:

• Developed a microscopic kinetic model of PGHS-1 involving 35 intraenzyme reactions and 24 intermediate states.
• Calibrated the model using in vitro kinetic data.
• Validated the model using experimental data on PGHS-1 regulatory properties.

Main Results:

• The model quantitatively describes PGHS-1's interconnected cyclooxygenase and peroxidase activities.
• It accounts for substrate consumption, enzyme inactivation, and product synthesis (PGG2, PGH2).
• The model accurately reflects experimental data on enzyme regulation.

Conclusions:

• A validated, comprehensive kinetic model of PGHS-1 with unified parameters is established.
• This model enables in silico screening of NSAIDs and their combinations.
• It predicts NSAID impact on the balance of pro-thrombotic and anti-thrombotic prostaglandins.